While local anesthetic systemic toxicity (LAST) remains a serious concern in clinical practice, several preventive measures have been proposed to reduce its occurrence. A proactive approach, focusing on minimizing risk factors through careful dosing, injection techniques, and monitoring, is critical. The aim is not to eliminate risk entirely but to create conditions where the likelihood of LAST is significantly diminished.
Use the Lowest Effective Dose of Local Anesthetics
A key strategy in preventing LAST is using the lowest effective dose of local anesthetics tailored to the individual patient. Dosing should be based on factors such as body mass, the site of injection, the patient's age, and their overall medical history. In particular, obese patients should have their dosage calculated based on lean body weight rather than total body weight. This is because the excess adipose tissue in obese patients does not have the same capacity to absorb or metabolize local anesthetics, and dosing based on total body weight can result in dangerously high plasma levels of the drug.
Incremental injection techniques are another important precaution. Rather than administering a single large bolus of local anesthetic, clinicians should inject smaller volumes—typically 3 to 5 mL aliquots—pausing for 15 to 30 seconds between injections. This approach allows for more careful monitoring of any early signs of systemic toxicity. Pausing for a time interval equivalent to one circulation time (roughly 30 to 45 seconds) before each injection is important to ensure that any inadvertently injected anesthetic has time to be distributed and metabolized before the additional drug is introduced. This interval may need to be extended in patients with decreased cardiac output or during lower extremity blocks, as systemic circulation can be slower in these scenarios.
Aspirating and Using Intravascular Markers
Another commonly recommended step is to aspirate before each injection to ensure that the needle is not in a blood vessel. However, it is important to recognize that this technique has a false-negative rate of about 2%, meaning that a negative aspiration result does not guarantee that intravascular injection has been avoided. Even so, this measure adds an additional layer of safety.
For each aliquot, aspirate, inject 3 to 5 mL, pause one circulation time, and watch for an epinephrine marker response; observe the patient afterward and let ultrasound, lean-body-weight dosing, and the time-out limit the total dose.
In addition to aspiration, the use of intravascular markers, such as epinephrine, has been advocated to help detect accidental intravascular injection. An intravascular injection of epinephrine will produce a detectable cardiovascular response, including an increase in heart rate by at least 10 beats per minute (bpm) and an increase in systolic blood pressure by at least 15 mmHg in most adults. However, the use of epinephrine as a marker is not without its limitations. Beta-blocked patients, elderly patients, and those under general anesthesia may not exhibit these characteristic hemodynamic responses to epinephrine, reducing its effectiveness as a marker of intravascular injection. Additionally, in pregnant women, uterine contractions can result in false-positive responses, complicating the interpretation of epinephrine's effects. In children, the recommended dose of epinephrine is 0.5 mcg/kg, which should result in an increase in systolic blood pressure by at least 15 mmHg.
| Measure | How to apply it | Limitation |
|---|---|---|
| Lowest effective dose | Individualize to body mass, injection site, age and medical history | — |
| Dose by lean body weight in obesity | Calculate on lean body weight, not total body weight | Total-body-weight dosing can produce dangerously high plasma levels |
| Incremental injection | 3–5 mL aliquots, pausing 15–30 s; allow one circulation time (~30–45 s) before each injection | Extend the interval with low cardiac output or lower-extremity blocks |
| Aspirate before each injection | Checks for intravascular needle placement | ~2% false-negative rate — a negative aspiration does not guarantee safety |
| Epinephrine as an intravascular marker | Intravascular injection raises heart rate by ≥10 bpm and systolic BP by ≥15 mmHg in most adults; children 0.5 mcg/kg (SBP rise ≥15 mmHg) | Unreliable in beta-blocked, elderly or generally anesthetized patients; uterine contractions cause false positives |
| Ultrasound guidance | Real-time needle visualization, especially for paravertebral and brachial plexus blocks | Reduces LAST risk by up to 65% versus landmark or nerve-stimulator technique — but does not eliminate it |
Ultrasound Guidance
Ultrasound guidance is a valuable tool in reducing the risk of LAST, particularly during peripheral nerve blocks. By providing real-time visualization of the needle and surrounding structures, ultrasound allows for more precise placement of local anesthetics, significantly reducing the likelihood of inadvertent intravascular injection. Studies have shown that the use of ultrasound can reduce the risk of LAST by up to 65% compared to traditional localization methods such as nerve stimulation or anatomical landmarks. The precision of ultrasound guidance is especially beneficial in high-risk blocks, such as paravertebral and brachial plexus blocks, where the risk of vascular puncture is higher due to the close proximity of large blood vessels.
Consideration of Additive Toxicity
Clinicians must also be aware of the additive nature of local anesthetic toxicity. Combining different local anesthetics, re-dosing anesthetics, or administration by multiple perioperative providers can result in cumulative toxicity. Even if the doses of individual anesthetics are within safe limits, their combined effect can push plasma concentrations into the toxic range. For example, using both lidocaine and bupivacaine during the same procedure can increase the risk of LAST due to their additive effects on the central nervous system and cardiovascular system.
Similarly, continuous infusions of local anesthetics—such as those used for postoperative analgesia—require careful monitoring. Plasma levels of the anesthetic can accumulate over time, particularly during the first 1 to 4 days of infusion, potentially reaching toxic levels even if the infusion rate is relatively low. It is important to adjust doses for the duration of infusion, the block site, and patient-specific factors, such as comorbidities or age.
Special Considerations for Truncal Blocks and High-Risk Patients
During truncal blocks, clinicians should use a lower concentration of local anesthetics, dose based on lean body weight, and consider using epinephrine as a marker for intravascular injection. These blocks have a higher potential for systemic toxicity due to the vascularity of the injection site. It is also recommended that clinicians observe patients for at least 30 to 45 minutes after a block, particularly when higher or potentially toxic doses of local anesthetic have been used.
Certain patient populations are at inherently higher risk for LAST and require extra precautions. These groups include young children, elderly patients, those with renal, hepatic, or cardiac disease, and malnourished patients. In these populations, the metabolism and clearance of local anesthetics may be impaired, increasing the risk of toxicity. Adjusting doses based on patient characteristics, such as weight, comorbidities, and organ function, is critical in these cases.
Monitoring and Safety Protocols
Vigilant monitoring remains a cornerstone of LAST prevention. Patients who receive potentially toxic doses of local anesthetics should be closely observed for at least 30 minutes after the injection. This period allows for early detection of any signs or symptoms of toxicity, such as agitation, confusion, or cardiovascular changes, which can be addressed promptly before they progress to more severe outcomes like seizures or cardiac arrest.
To further improve safety, including the maximum local anesthetic dose in the surgical time-out process is recommended. This ensures that all members of the surgical and anesthesia teams are aware of the dosing limits and can avoid inadvertently exceeding safe doses, especially in complex procedures where multiple providers may be administering local anesthetics.
| Situation | Why the risk rises | Precaution |
|---|---|---|
| Combining or re-dosing local anesthetics | Effects are additive — individually safe doses can sum into the toxic range (e.g., lidocaine plus bupivacaine) | Track the total dose given by every perioperative provider |
| Continuous infusions for postoperative analgesia | Plasma levels accumulate over the first 1–4 days even at low infusion rates | Adjust for infusion duration, block site, comorbidities and age |
| Truncal blocks | Vascular injection sites raise systemic uptake | Lower concentration, dose by lean body weight, use epinephrine as a marker |
| Higher-risk patients — young children, elderly, renal, hepatic or cardiac disease, malnourished | Impaired metabolism and clearance | Adjust dose for weight, comorbidities and organ function |
| After a potentially toxic dose | Early signs (agitation, confusion, cardiovascular change) precede seizures and arrest | Observe at least 30 min (30–45 min after a block with high doses) |
| Team awareness | Multiple providers may each administer local anesthetic | State the maximum local anesthetic dose during the surgical time-out |
